ArticleInternational journal of women's health2025
Pregnancy-Triggered Hereditary Thrombotic Thrombocytopenic Purpura: A Case Report.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hereditary thrombotic thrombocytopenic purpura (hTTP), as an autosomal recessive hereditary disease, pregnancy is one of its recognized trigger factors. The lag in the diagnosis and treatment of this disease can lead to serious adverse pregnancy outcomes. In clinical practice, a high degree of vigilance should be maintained and timely treatment should be given to strive for better pregnancy outcomes. Case Presentation: A 36-year-old woman has undergone 4 pregnancies over a period of 25 years. Due to the insufficient diagnosis capabilities at that time, it was not until the 3rd pregnancy when the patient again presented with severe thrombocytopenia in the second trimester that she was diagnosed with hTTP in our hospital. However, since the optimal treatment opportunity was missed, even though active plasma infusion was carried out, fetal death still occurred. In 2024, the patient got pregnant again, and this was her 4th pregnancy. During this pregnancy, the patient underwent preventive plasma infusion therapy throughout and no serious complications emerged. Ultimately, she gave birth to a full-term baby in February 2025. Conclusion: We report a case of hTTP caused by complex compound heterozygous gene mutations. Currently, pregnancy is the only trigger for the patient's illness. Timely identification, early differential diagnosis from obstetric complications, and active management are crucial for improving the pregnancy outcome of hTTP patients. We adopted a more conservative strategy of prophylactic plasma infusion during pregnancy and also achieved good maternal and fetal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.